The FDA has approved Steqeyma® (ustekinumab-stba), a biosimilar to Stelara®, for the treatment of various chronic ...

Life expectancy in the United States increased in 2023, reaching 78.4 years, while drug overdose mortality decreased from ...

Light-to-moderate consumption of wine, measured through an objective urinary biomarker, is associated with lower CVD risk in ...

In COPD, patients with abnormally high exertional breathlessness on CPET are unlikely to be identified via standard symptom ...

The US FDA wants to redefine the meaning of healthy food, issuing a new rule that changes the way food companies can claim ...

The US FDA re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss medication ...

RSVpreF vaccination is effective against RSV-related lower respiratory tract disease among adults aged 60 years or older.

Increased CVD incidence is observed in patients with vs without TB, particularly within months of TB diagnosis, regardless of ...

The use of influenza testing at hospital emergency department visits increased from 2013 to 2022 in the United States.

Pulmonologist sued for medical malpractice sought to have the case dismissed on the grounds that testimony supporting the ...

The FDA has approved Vtama® (tapinarof) cream 1% for the topical treatment of atopic dermatitis in patients aged 2 years and older.

Lower pulmonary microvascular blood volume (PMBV) is associated with greater percent emphysema in those with a diffuse emphysema subtype.